Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The increasing importance given to advanced biological therapies for wound healing has led to dynamic growth in this sector. Innovations resulting from deep insights into the process of treating wounds through the application of biotechnology have resulted in novel forms of wound dressing medication currently used today by medical practitioners across the globe. Key factors driving this trend include higher incidence rates for chronic wounds like diabetic foot ulcers (DFU), pressure ulcers (PU), and venous leg ulcers (VLU), which are the main reasons behind positive growth dynamics in the area of wound care biologics. Increasingly, as the major chronic disease's global burden heightens, one of its direct consequences is a rise in long-lasting wound cases. Patient outcomes can be improved through wound healing biologics that are focused and have bio-active properties that deal with the peculiarities associated with this kind of ailment.
Regulatory factors play a critical role in shaping the dynamics of the wound care biologics market. Strict regulations and standards guarantee biological safety, efficacy, and quality. The aging population and increasing awareness about modern wound care solutions greatly affect development trends within the wound healing biologic industry. In global terms, along with aging populations comes a greater prevalence of chronic wounds related to aging, such as pressure ulcers. Other economic considerations, as well as healthcare reimbursement policies, also shape market dynamics. The affordability of organizations involved in providing these drugs to various healthcare settings is likely to determine their adoption rates.
Key players' competition serves as another driver for changing patterns observed among Wound Care Biologics Market medical practitioners. There's an emphasis on differentiating their products based on things like how effective they are as well as how easy it is to use them on different types of human injuries caused by accidents or diseases. The research aims to broaden the application field of new age promptitude by making it The COVID-19 pandemic has changed everything; now it becomes clearer how important advanced wound care is for overall health systems. Survival rate concerns were at hand when efforts were directed towards containing the COVID-19 pandemic. Still, after realizing that most complications arise from poor management of wounds, there emerged a need for the adoption of advanced technology-based medicine, commonly referred to as biologicals used in wound treatment.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Product Type, Wound Type, and End User |
Wound Care Biologics Market Highlights:
Global Wound Care Biologics Market Overview
Wound Care Biologics Market Size was valued at USD 1.90 Billion in 2023. The Global Wound Care Biologics industry is projected to grow from USD 2.10 Billion in 2024 to USD 2.40 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.76% during the forecast period (2024 - 2032).
Wound care biologics products help the body repair wounds naturally by creating an active healing environment. Diabetic ulcers, venous ulcers, arterial ulcers, and pressure ulcers are the most common wounds treated with biologics.
The wound care biologics market is predicted to develop due to reasons such as the rising prevalence of chronic illnesses and burn injuries, as well as rising healthcare spending. According to the Centers for Disease Control and Prevention (CDC), around 2.8 million persons were admitted to hospitals owing to injuries in 2015. Over the projection period, however, the wound care biologics market will be hampered by high treatment costs, a lack of awareness, and insufficient education and training.
Wound Care Biologics Market Segment Insights
The wound care biologics market has been segmented into product type, wound type, and end user.
Wound Care Biologics Product Type Insights
Based on product type, has been segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to account for the largest share and fastest growing segment of the market.
Wound Care Biologics Wound Type Insights
The market, by wound type, has been segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment has been further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcer, and others.
Wound Care Biologics End User Insights
The market, by end user, has been segmented into hospitals, ambulatory surgical centers, and clinics.
Wound Care Biologics Regional Insights
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wound care biologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European wound care biologics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The wound care biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wound care biologics market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
Some of the key players in the wound care biologics market are
- Integra LifeSciences Corporation (US)
- Smith & Nephew (UK)
- Wright Medical (US)
- Mölnlycke Health Care AB (Sweden)
- MiMedx Group (US)
- Vericel Corporation (US)
- Anika Therapeutics (US)
- Osiris Therapeutics (US)
- Marine Polymer Technologies, Inc. (US)
- Kerecis (Iceland)
- Solsys Medical (US)
- ACell (US)
- Organogenesis (US)
Regional Market Summary
Geographically, the Americas is anticipated to dominate the wound care biologics market owing to a well-developed healthcare sector, growing occurrences of chronic wounds, rising prevalence of diabetes and rising geriatric population. According to the National Diabetes Statistics Report 2017, about 30.3 million suffer from diabetes in Americans.
Europe is expected to hold the second largest position in the wound care biologics market. The market growth in this region is attributed to the increasing prevalence of diabetes and developed healthcare infrastructure.
The wound care biologics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the huge patient population of chronic diseases such as diabetes in countries such as India and China.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Recent Development
Wright Medical Group Inc. manufactures human replacement components. The company creates replacement joints for the foot, ankle, hand, elbow, shoulder, and other damaged joints. The IN BONE, CLAW, and ORTHOLOC systems for foot and ankles, as well as the MICRONAIL implants for wrist fractures, are among the product lines. Wright's goods are distributed in over 60 countries, with the United States being the main market. Wright Medical Group N.V. was formed in 2015 when the company merged with Tornier of the Netherlands.
MiMedx Group Inc. is a medical equipment manufacturer. Biomaterials for soft tissue repair, such as tendons, ligaments, and cartilage, are the company's main emphasis, as well as various biomaterial-based solutions for other medical purposes. The MiMedx Group is a global provider of medical services.
Intended Audience
- Wound Care Biologics Manufacturers and Vendors
- Various Research and Consulting Firms
- Wound Care Biologics Distributors
- Hospitals
Wound Care Biologics Market Segmentation
Wound Care Biologics Market Product Type Outlook
- Skin Substitute
- Human Donor Tissue
- Acellular animal-derived
- Biosynthetic
- Topical Agents
Wound Care Biologics Market Wound Type Outlook
- Ulcers
- Diabetic foot ulcers
- Venous ulcers
- Pressure ulcers
- Other ulcers
- Surgical and Traumatic Wounds
- Burns
Wound Care Biologics Market End User Outlook
- Hospitals
- Clinics
- Other End Users
Wound Care Biologics Market Region Outlook
- Americas
-
- North America
- US
- Canada
- South America
- Europe
-
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
-
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
-
- Middle East
- Africa
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
